Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BI 01383298

Copy Product Info
😃Good
Catalog No. T5324Cas No. 2227549-00-8

BI 01383298 is a selective inhibitor of the sodium-citrate co-transporter (SLC13A5).

BI 01383298

BI 01383298

Copy Product Info
😃Good
Purity: 99.71%
Catalog No. T5324Cas No. 2227549-00-8
BI 01383298 is a selective inhibitor of the sodium-citrate co-transporter (SLC13A5).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$46In StockIn Stock
25 mg$100In StockIn Stock
50 mg$163In StockIn Stock
100 mg$260In StockIn Stock
200 mg$370-In Stock
1 mL x 10 mM (in DMSO)$30In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.71%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

BI 01383298 AI Summary
BI 01383298 demonstrates cell-type-specific bioactivities impacting cell viability and protein thermal stability. In terms of cell viability, the compound shows varying effects: in HEK293T cells, growth rates range from negative (-0.42) to positive (up to 0.95); in U2OS cells, growth rates are consistently positive, ranging from 0.72 to 0.98; and in human fibroblasts, the growth rates vary between 0.3 and 0.84. This suggests that the compound can either inhibit or promote cell growth depending on the cell type. In protein thermal stability assays, BI 01383298 exhibits domain-specific effects with some domains showing increased stability (positive Delta TM values) and others decreased stability (negative Delta TM values). Specific domains such as M1-K294 and E122-S403 display increased stability, while domains like M1-L298 and M26-R383 exhibit decreased stability, indicating variable interaction kinetics across different protein regions. Additionally, BI 01383298 shows significant bioactivity in affinity-based cellular interactions, particularly targeting the citrate uptake inhibition assay in HepG2 cells expressing endogenous SLC13A5, with an IC50 value of 24.0 nM. Another report shows an IC50 value of 56.0 nM for the same assay. The compound also interacts with OPRK1, exhibiting 19.0% of control in the SafetyScreen44™ assay, indicating selective modulatory effects on this target..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BI 01383298 is a selective inhibitor of the sodium-citrate co-transporter (SLC13A5).
Chemical Properties
Molecular Weight445.34
FormulaC19H19Cl2FN2O3S
Cas No.2227549-00-8
SmilesFc1ccc(CNC(=O)C2CCN(CC2)S(=O)(=O)c2cc(Cl)cc(Cl)c2)cc1
Relative Density.1.419 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 22 mg/mL (49.4 mM), Sonication is recommended.
H2O: Insoluble
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2455 mL11.2274 mL22.4548 mL112.2738 mL
5 mM0.4491 mL2.2455 mL4.4910 mL22.4548 mL
10 mM0.2245 mL1.1227 mL2.2455 mL11.2274 mL
20 mM0.1123 mL0.5614 mL1.1227 mL5.6137 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BI 01383298 | purchase BI 01383298 | BI 01383298 cost | order BI 01383298 | BI 01383298 chemical structure | BI 01383298 formula | BI 01383298 molecular weight